查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1940085

關節鏡檢查設備產品、手術、最終用戶和通路分類，全球預測（2026-2032年）

Arthroscopy Equipment Market by Product, Procedure, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，關節鏡檢查設備市場價值將達到 30.2 億美元，到 2026 年將成長至 32.4 億美元，到 2032 年將達到 52.3 億美元，複合年成長率為 8.16%。

關鍵市場統計數據
基準年 2025 30.2億美元
預計年份：2026年 32.4億美元
預測年份 2032 52.3億美元
複合年成長率 (%) 8.16%

策略性應用：臨床創新、醫療服務轉型與採購趨勢共同塑造關節鏡檢查設備的未來

關節鏡檢查設備處於外科創新、醫療系統效率和以患者為中心的護理三者的關鍵交匯點。器械、視覺化技術和植入設計的進步，已逐步將微創關節手術轉變為整形外科領域的標準治療方法，從而縮短了患者的康復時間並減少了住院資源的消耗。同時，隨著醫療服務轉移到門診診所和日間手術中心，採購重點也在發生變化，轉向緊湊、互通性且能提供可重複臨床結果並降低資本成本的系統。

全面概述正在重新定義關節鏡檢查設備應用和採購模式的技術、臨床和商業性變革

由於技術、臨床和商業性因素的融合，關節鏡檢查設備市場格局正在經歷變革性變化。首先，高清視覺化技術和整合成像平台的進步正在重新定義外科醫生對術中清晰度和決策支援的期望。如今，對攝影機、光源和顯示器的評估不僅關注其光學性能，還越來越重視互通性與軟體分析、擴增實境疊加和雲端病例記錄的互通性。因此，視覺化系統不再只是獨立的資本投資，而是正在成為更廣泛的數位化手術室策略的核心。

分析2025年計畫中的關稅調整對關節鏡檢查設備成本結構、籌資策略以及整個價值鏈採購風險的整體影響

計劃於2025年實施的關稅和貿易政策調整的累積影響，正對關節鏡檢查設備系統的成本結構、供應鏈和採購決策造成巨大壓力。高度依賴進口的細分市場，例如特種植入和先進視覺化模組，由於其依賴精密零件和分佈在多個地區的垂直整合製造模式，最容易受到關稅轉嫁的影響。隨著關稅增加，到岸成本上升，採購組織面臨著複雜的權衡：一方面要維持與現有供應商的關係，另一方面又要尋求在地採購和近岸外包方案，以降低關稅波動風險，但這些方案需要資本投資和漫長的資質認證週期。

可操作的細分洞察，揭示產品層級、流程多樣性、終端使用者畫像和分銷管道如何共同塑造商業策略和臨床應用。

細分市場洞察揭示了產品、手術流程、終端用戶和分銷管道等不同維度的需求促進因素和商業化挑戰。在產品方面，市場可以從流體管理系統、植入、器械和視覺化系統四個維度進行分析。流體管理系統可進一步細分為灌注系統和泵，植入為硬組織和軟組織解決方案，器械可細分為軟性、電動和剛性類型，視覺化系統可細分為攝影機、光源和顯示器。這種多層次的產品細分錶明，對某一功能領域的投資往往會帶動其他領域的互補需求。例如，先進視覺化平台的引入通常會增加對相容攝影機和顯示器的需求，同時也會影響器械的人體工學設計和植入的選擇。

美洲、歐洲、中東和非洲以及亞太地區的主要區域趨勢和市場特徵將影響產品採用優先順序、監管要求和分銷策略。

區域趨勢持續影響美洲、歐洲、中東和非洲以及亞太地區的投資重點、監管複雜性和產品應用速度。美洲地區擁有成熟的醫院系統和不斷發展的門診手術中心網路，因此既需要高性能的整合式手術室解決方案，也需要適用於門診環境的緊湊高效設備。儘管該地區通常在早期臨床應用和機構間採購協議方面發揮主導作用，但其複雜的報銷機制也會影響設備的選擇和合約策略。

為了在關節鏡檢查設備領域保持競爭力，各公司正在實施產品組合擴展、以服務為中心的經營模式和供應鏈策略等公司層面的發展趨勢。

為了因應競爭壓力和臨床需求，業內相關人員正尋求產品系列整合、策略聯盟和產能擴張等多面向措施。領先的製造商正在拓展其視覺化技術和數位化解決方案，透過可互通的攝影機、光源和顯示器，結合分析和病例記錄工作流程，建構生態系統。同時，業界也高度重視擴展器械套件，以滿足柔軟性、電動和剛性器械的需求，從而使供應商能夠提供端到端的整套手術工具包，降低整個醫療系統的整體擁有成本。

為製造商和醫療保健系統領導者提供實際有效的建議，以協調創新、供應鏈韌性和商業模式，從而實現關節鏡檢查設備的持續成長。

為了在不斷變化的醫療保健領域創造價值，產業領導者必須將產品創新與採購實際情況結合。首先，他們應優先開發可互通的可視化平台和與生態系統相容的儀器，以減少醫院和門診中心之間的整合摩擦。投資於攝影機、光源和顯示器的兼容性，並結合標準化的軟體介面，將最大限度地降低部署複雜性，並透過展現可衡量的工作流程優勢來加速產品應用。

透明的調查方法結合了臨床醫生訪談、資訊來源洞察以及跨地域和產品層級的嚴格資料三角驗證，從而得出可操作的結論。

本次高階主管分析的調查方法結合了定性專家訪談、有針對性的二手資料研究以及多元資料來源的三角驗證，以確保獲得可靠且可操作的洞見。主要資訊來自對骨科醫生、手術護士、醫院和門診手術中心的採購人員以及配銷通路高管的結構化訪談，旨在獲取有關臨床需求、採購標準和運營限制的第一手資料。此外，還透過整合監管指南、醫療設備認證趨勢和已發表的臨床文獻等二手資料研究，檢驗了該技術的性能和安全性。

一份權威的綜合分析報告，重點闡述了技術、採購和區域趨勢之間的相互作用，這些因素將塑造關節鏡檢查設備。

總之，關節鏡檢查設備市場環境的特徵是技術標準不斷提高、臨床實踐不斷改變以及商業性整合三者相互融合。視覺化技術的進步、模組化器械設計、植入創新以及更智慧的流體管理正在共同提升臨床標準並重塑採購重點。同時，關稅壓力和通路正在推動供應鏈的調整和服務導向型經營模式的轉變，從而將資本投資轉化為可衡量的臨床和營運價值。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章關節鏡檢查設備市場（依產品分類）

  • 體液管理系統
    • 灌注系統
    • 泵浦
  • 植入
    • 硬組織
    • 軟組織
  • 裝置
    • 靈活的
    • 電的
    • 硬度
  • 視覺化系統
    • 相機
    • 光源
    • 監視器

第9章 依手術類型分類的關節鏡檢查設備市場

  • 踝
  • 彎頭
  • 髖關節
  • 膝蓋
  • 肩膀
  • 手腕

第10章 依最終用戶分類的關節鏡檢查設備市場

  • 門診手術中心
  • 診所
  • 醫院

第11章 按分銷管道分類的關節鏡檢查設備市場

  • 直接購買
  • 線上管道
  • 第三方供應商

第12章 各地區關節鏡檢查設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章關節鏡檢查設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國關節鏡檢查設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國關節鏡檢查設備市場

第16章 中國關節鏡檢查設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • A3 Surgical
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • Cannuflow, Inc.
  • ClearCut Medical, LTD
  • CONMED Corporation
  • EndoMed Systems GmbH
  • Henke Sass Wolf GmbH
  • Johnson & Johnson
  • JOIMAX GmbH
  • Karl Storz SE & Co. KG
  • MEDICON eG
  • Medtronic plc
  • NDI Medical LLC
  • Richard Wolf GmbH
  • Sklar Corporation
  • Smith & Nephew plc
  • STERIS plc
  • Stryker Corporation
  • TK Orthopedic & Medical Devices Corporation
  • Trice Medical, Inc.
  • Vimex Sp. z oo
  • VirtaMed AG
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-546E6FBB3B96

The Arthroscopy Equipment Market was valued at USD 3.02 billion in 2025 and is projected to grow to USD 3.24 billion in 2026, with a CAGR of 8.16%, reaching USD 5.23 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.02 billion
Estimated Year [2026] USD 3.24 billion
Forecast Year [2032] USD 5.23 billion
CAGR (%) 8.16%

A strategic introduction that frames how clinical innovation, care delivery shifts, and procurement dynamics collectively shape the future of arthroscopy equipment

Arthroscopy equipment occupies a pivotal intersection of surgical innovation, health system efficiency, and patient-centered care. Advances in instrumentation, visualization, and implant design have steadily transformed minimally invasive joint procedures into standard practice across orthopedics, enabling faster recovery times and reducing inpatient resource utilization. Concurrently, shifts in care delivery toward ambulatory settings and outpatient surgery centers have reoriented procurement priorities toward compact, interoperable systems that deliver repeatable clinical outcomes while minimizing capital footprint.

This introduction sets the foundation for an executive review that synthesizes technology trends, procedural demand dynamics, end-user behavior, distribution strategies, and regulatory developments shaping the arthroscopy equipment landscape. It draws on product-level distinctions between fluid management systems, implants, instruments, and visualization systems to highlight how modularity and system ecosystems influence purchasing decisions. It also contextualizes procedural drivers across anatomical applications such as ankle, elbow, hip, knee, shoulder, and wrist interventions to illustrate how clinical practice patterns inform device design and training investments.

Moreover, the content acknowledges the evolving roles of ambulatory surgery centers, clinics, and hospitals in routing case volume and capital expenditures, and it addresses how direct purchase, online channels, and third-party suppliers are redefining supplier relationships. Taken together, this section frames the subsequent analysis by clarifying the structural forces that will determine competitive positioning, innovation priorities, and adoption pathways for arthroscopy equipment in the near to medium term.

A comprehensive overview of the transformative technological, clinical, and commercial shifts that are redefining arthroscopy equipment adoption and procurement patterns

The landscape for arthroscopy equipment is undergoing transformative shifts driven by converging technological, clinical, and commercial forces. First, advancements in high-definition visualization and integrated imaging platforms are redefining surgeon expectations for intraoperative clarity and decision support. Cameras, light sources, and monitors are increasingly judged not only on optical performance but also on interoperability with software analytics, augmented reality overlays, and cloud-enabled case documentation. As a result, visualization systems are becoming central to broader digital operating room strategies rather than isolated capital purchases.

Second, instrumentation is trending toward modularity and ergonomics, with flexible, powered, and rigid instrument families evolving to support procedure-specific workflows while enabling sterilization and reprocessing efficiencies. Flexible instruments are facilitating access in anatomically constrained joints, powered devices are improving soft-tissue work efficiency, and rigid tools retain core roles in established procedural steps. These instrument-level innovations are complemented by implant developments that emphasize biologic integration and material science advances across hard tissue and soft tissue portfolios, enhancing clinical outcomes while also raising questions about long-term supply chain transparency.

Third, fluid management systems-encompassing irrigation systems and pumps-are receiving renewed attention because they directly affect procedural safety, operative visibility, and workflow throughput. Integration of sensor-based flow control and closed-loop feedback mechanisms is enabling more predictable intra-articular environments and reducing complication risk. Finally, the commercial landscape is transforming as distribution channels diversify: direct purchase relationships remain critical for major hospital systems, online channels are gaining traction for non-implant consumables and instruments, and third-party suppliers play an increasingly strategic role in retrofit and maintenance ecosystems. These shifts are altering procurement cycles, influencing device design priorities, and creating new opportunities for cross-functional collaboration among clinical, supply chain, and commercial stakeholders.

An analysis of how tariff changes slated for 2025 collectively affect arthroscopy equipment cost structures, sourcing strategies, and procurement risk across the value chain

The cumulative effect of tariff actions and trade policy adjustments announced for implementation in 2025 is exerting material pressure on cost structures, supply chains, and sourcing decisions within the arthroscopy equipment ecosystem. Import-dependent segments such as specialized implants and sophisticated visualization modules are most sensitive to tariff pass-through because they rely on precision components and vertically integrated manufacturing located across multiple geographies. As tariffs increase landed costs, purchasing organizations face complex trade-offs between preserving existing supplier relationships and pursuing localization or nearshoring options that may reduce exposure to tariff volatility but require capital investment and longer qualification cycles.

In addition, tariff-driven cost pressures are accelerating supplier strategies to mitigate margin impact. Manufacturers are pursuing component redesign to reduce reliance on tariff-exposed parts, renegotiating contractual terms with distributors, and selectively shifting production to lower-tariff jurisdictions. These responses create a ripple effect across the procurement chain: third-party suppliers recalibrate inventory positions to avoid duty spikes, online channel operators assess pricing transparency implications, and ambulatory surgery centers with tighter capital budgets prioritize durable multi-use systems over single-use disposables to manage recurrent expenses.

Regulatory and compliance considerations are also implicated because sourcing changes can require additional validation, quality audits, and inventory replenishment planning. Consequently, clinical adoption timelines for new implants or instruments may extend as hospitals and clinics balance clinical value against procurement risk. Finally, the tariff environment has strengthened the business case for integrated service offerings-bundling equipment with maintenance, training, and performance guarantees-to justify higher upfront costs with predictable lifecycle outcomes. In sum, the cumulative tariff impact in 2025 is prompting both immediate cost containment responses and longer-term strategic realignment across manufacturing, distribution, and purchasing behaviors.

Actionable segmentation insights revealing how product hierarchies, procedural variation, end-user profiles, and distribution channels together shape commercial strategies and clinical adoption

Segmentation insights reveal differentiated demand drivers and commercialization challenges across product, procedure, end-user, and distribution dimensions. On the product front, the market can be examined across fluid management systems, implants, instruments, and visualization systems, with further granularity such that fluid management systems encompass irrigation systems and pumps; implants bifurcate into hard tissue and soft tissue solutions; instruments separate into flexible, powered, and rigid types; and visualization systems span cameras, light sources, and monitors. This layered product segmentation underscores how investment in one functional area often cascades into complementary needs in another-adoption of advanced visualization platforms, for example, typically increases demand for compatible cameras and monitors while also influencing instrument ergonomics and implant selection.

Examining procedures across ankle, elbow, hip, knee, shoulder, and wrist provides a clinical lens that highlights variable procedure volumes, reimbursement nuances, and training requirements. Knee and shoulder arthroscopies frequently drive baseline demand for a broad spectrum of devices, whereas ankle, elbow, hip, and wrist procedures can create pockets of specialized instrument and implant requirements that command premium pricing and bespoke training programs. From an end-user perspective, ambulatory surgery centers, clinics, and hospitals display divergent purchasing behaviors: ambulatory centers emphasize throughput, turnover time, and equipment footprint; clinics prioritize cost-effectiveness and ease of use for routine interventions; hospitals focus on system compatibility, high-acuity capabilities, and long-term service contracts.

Finally, distribution channel segmentation across direct purchase, online channels, and third-party suppliers illustrates how procurement complexity has increased. Direct purchase relationships enable deep integration and customized service levels with strategic suppliers, online channels facilitate rapid replenishment of consumables and standardized instruments, and third-party suppliers provide flexibility for hospitals and clinics seeking cost containment through contract manufacturing and equipment refurbishment. Collectively, these segmentation perspectives illuminate where innovation, commercialization effort, and sales resource allocation should be concentrated to capture differentiated clinical and purchasing value.

Key regional dynamics and market characteristics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine adoption priorities, regulatory demands, and distribution strategies

Regional dynamics continue to shape investment priorities, regulatory complexity, and adoption velocities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a concentrated mix of mature hospital systems and a growing network of ambulatory surgery centers creates demand for both high-performance, integrated operating room solutions and compact, efficient devices suited to outpatient environments. This region often leads on early clinical adoption and institutional purchasing agreements, while also presenting complex reimbursement pathways that influence device selection and contracting strategies.

Across Europe, Middle East & Africa, heterogeneity is a defining feature: established markets in Western Europe emphasize regulatory rigor, evidence-based procurement, and Sustainability-linked procurement criteria, whereas markets in the Middle East & Africa may prioritize rapid capacity expansion and public-private partnership models. Variability in reimbursement models and procurement centralization across these jurisdictions affects how vendors structure regional distribution and support networks.

Asia-Pacific combines rapid procedure volume growth with diverse market maturity levels. Developed markets in East Asia exhibit strong demand for cutting-edge visualization and robotics-enabled adjuncts, while emerging markets prioritize cost-effective implant and instrument solutions and scalable service models. Across all regions, supply chain resilience, localization strategies, and training infrastructure are critical determinants of successful market entry and expansion, and these regional distinctions should inform commercial segmentation and partnership approaches for vendors seeking to optimize resource allocation and deployment timelines.

Company-level trends highlighting portfolio expansion, service-centric business models, and supply chain strategies that firms are deploying to sustain competitiveness in arthroscopy equipment

Industry participants are responding to competitive pressure and clinical demand by pursuing a mix of portfolio consolidation, strategic partnerships, and capability expansion. Leading manufacturers are expanding their visualization and digital offerings to create ecosystem lock-in through interoperable cameras, light sources, and monitors that integrate with analytics and case documentation workflows. At the same time, there is a noticeable emphasis on broadening instrument suites to cover flexible, powered, and rigid tool needs, enabling vendors to offer end-to-end procedural kits that lower total cost of ownership for health systems.

In the implant arena, players are differentiating through material science innovations and biologic-compatible designs for both hard tissue and soft tissue applications. These advancements are complemented by service-oriented models, including training programs, outcome monitoring, and bundled maintenance agreements that strengthen customer relationships and create recurring revenue pathways. Commercially, companies are balancing direct purchase engagements with hospitals against expanding presence in online channels and third-party supplier networks to capture demand across ambulatory surgery centers and clinics.

Operationally, suppliers are investing in nearshoring, supplier diversification, and automation to reduce exposure to tariff-driven cost volatility and to shorten lead times. Strategic collaborations with equipment refurbishment firms and third-party logistics providers have emerged as pragmatic approaches to extend asset lifecycles and preserve margin while meeting hospital sustainability objectives. Taken together, these company-level responses reflect a pragmatic blend of technological differentiation, service augmentation, and supply chain optimization aimed at sustaining growth and meeting evolving clinical expectations.

Practical, high-impact recommendations for manufacturers and health system leaders to align innovation, supply chain resilience, and commercial models for sustained growth in arthroscopy equipment

Industry leaders must align product innovation with practical procurement realities to capture value across evolving care settings. First, prioritize development of interoperable visualization platforms and ecosystem-compatible instruments that reduce integration friction for hospitals and ambulatory centers. Investments in camera, light source, and monitor compatibility, coupled with standardized software interfaces, will accelerate adoption by minimizing implementation complexity and demonstrating measurable workflow benefits.

Second, diversify manufacturing footprints and establish strategic supplier redundancy to mitigate tariff and geopolitical risks. Nearshoring select production lines for implants and critical visualization components can reduce lead times and duty exposure, while contract manufacturing partnerships can provide flexible capacity during demand fluctuations. Third, design service packages that bundle equipment, maintenance, and training to convert higher upfront costs into predictable lifecycle value for purchasers. This approach addresses buyer concerns about total cost of ownership and supports long-term clinical outcomes through structured training and performance monitoring.

Fourth, tailor commercial models by end-user segment: offer compact, cost-efficient systems and rapid replenishment options for clinics and ambulatory surgery centers, while delivering integrated, high-acuity solutions with extended service contracts for hospitals. Finally, engage proactively with supply chain stakeholders and payers to communicate the clinical and economic value of innovations, supporting reimbursement alignment and smoother procurement pathways. Executing on these recommendations will require aligned investment in R&D, commercial capabilities, and cross-functional program management to ensure timely market entry and sustainable adoption.

A transparent research methodology integrating clinician interviews, procurement insights, and rigorous data triangulation across regions and product hierarchies to ensure actionable conclusions

The research methodology underpinning this executive analysis combines qualitative expert interviews, targeted secondary research, and triangulation of diverse data sources to ensure robust, actionable findings. Primary inputs were derived from structured interviews with orthopedic surgeons, surgical nurses, procurement leaders across hospitals and ambulatory centers, and distribution channel executives to capture firsthand perspectives on clinical needs, purchasing criteria, and operational constraints. These insights were complemented by secondary research that synthesized regulatory guidance, device approval trends, and published clinical literature to validate technology performance and safety considerations.

Data triangulation involved cross-referencing interview findings with vendor product specifications, public procurement policies, and observable distribution patterns to minimize bias and enhance the reliability of conclusions. The methodology prioritized clarity on device-level distinctions-such as irrigation systems versus pumps within fluid management, hard tissue versus soft tissue implants, and instrument typologies including flexible, powered, and rigid tools-so that segmentation-driven implications could be reliably inferred. Regional and procedural variations were incorporated through targeted stakeholder input from the Americas, Europe, Middle East & Africa, and Asia-Pacific to reflect diverse adoption environments.

Finally, analytical rigor was maintained through iterative validation with practicing clinicians and supply chain professionals, ensuring that the synthesized insights are actionable, clinically relevant, and sensitive to procurement realities. The methodology emphasizes transparency in source types and analytical assumptions while deliberately excluding speculative market sizing or forecasting to maintain focus on strategic implications and operational recommendations.

A conclusive synthesis emphasizing the interplay of technology, procurement, and regional dynamics that will determine future adoption and strategic priorities in arthroscopy equipment

In conclusion, the arthroscopy equipment landscape is defined by a convergence of technological elevation, shifting care settings, and commercial realignment. Visualization advancements, modular instrument design, implant innovation, and smarter fluid management are collectively raising the clinical bar and reshaping procurement priorities. At the same time, tariff pressures and distribution channel diversification are incentivizing supply chain adaptation and service-oriented business models that convert capital investments into demonstrable clinical and operational value.

Successful organizations will be those that combine technical differentiation with pragmatic commercial execution: delivering interoperable systems that simplify integration for hospitals and ambulatory centers, establishing resilient manufacturing and sourcing strategies to reduce exposure to policy-driven cost shocks, and crafting bundled service offerings that align purchaser incentives with long-term clinical outcomes. Regional nuances across the Americas, Europe, Middle East & Africa, and Asia-Pacific demand tailored approaches that reflect local regulatory environments, reimbursement frameworks, and infrastructure maturity.

Ultimately, the path forward requires coordinated investments in product ecosystems, supply chain flexibility, and outcome-focused commercialization to ensure that arthroscopy equipment innovations translate into sustained adoption and measurable improvements in patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Arthroscopy Equipment Market, by Product

  • 8.1. Fluid Management Systems
    • 8.1.1. Irrigation Systems
    • 8.1.2. Pumps
  • 8.2. Implants
    • 8.2.1. Hard Tissue
    • 8.2.2. Soft Tissue
  • 8.3. Instruments
    • 8.3.1. Flexible
    • 8.3.2. Powered
    • 8.3.3. Rigid
  • 8.4. Visualization Systems
    • 8.4.1. Cameras
    • 8.4.2. Light Sources
    • 8.4.3. Monitors

9. Arthroscopy Equipment Market, by Procedure

  • 9.1. Ankle
  • 9.2. Elbow
  • 9.3. Hip
  • 9.4. Knee
  • 9.5. Shoulder
  • 9.6. Wrist

10. Arthroscopy Equipment Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Arthroscopy Equipment Market, by Distribution Channel

  • 11.1. Direct Purchase
  • 11.2. Online Channels
  • 11.3. Third-Party Suppliers

12. Arthroscopy Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Arthroscopy Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Arthroscopy Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Arthroscopy Equipment Market

16. China Arthroscopy Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. A3 Surgical
  • 17.6. Arthrex, Inc.
  • 17.7. B. Braun Melsungen AG
  • 17.8. Cannuflow, Inc.
  • 17.9. ClearCut Medical, LTD
  • 17.10. CONMED Corporation
  • 17.11. EndoMed Systems GmbH
  • 17.12. Henke Sass Wolf GmbH
  • 17.13. Johnson & Johnson
  • 17.14. JOIMAX GmbH
  • 17.15. Karl Storz SE & Co. KG
  • 17.16. MEDICON eG
  • 17.17. Medtronic plc
  • 17.18. NDI Medical LLC
  • 17.19. Richard Wolf GmbH
  • 17.20. Sklar Corporation
  • 17.21. Smith & Nephew plc
  • 17.22. STERIS plc
  • 17.23. Stryker Corporation
  • 17.24. T. K. Orthopedic & Medical Devices Corporation
  • 17.25. Trice Medical, Inc.
  • 17.26. Vimex Sp. z o.o.
  • 17.27. VirtaMed AG
  • 17.28. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ARTHROSCOPY EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ARTHROSCOPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ARTHROSCOPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IRRIGATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IRRIGATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IRRIGATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY HARD TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY HARD TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY HARD TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY SOFT TISSUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY SOFT TISSUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY SOFT TISSUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY POWERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY POWERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY POWERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY ANKLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY ANKLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY ANKLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY ELBOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY ELBOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY ELBOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY HIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY HIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY HIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY KNEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY KNEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY SHOULDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY SHOULDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY SHOULDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY WRIST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY WRIST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY WRIST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DIRECT PURCHASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DIRECT PURCHASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DIRECT PURCHASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY THIRD-PARTY SUPPLIERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY THIRD-PARTY SUPPLIERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY THIRD-PARTY SUPPLIERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE ARTHROSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST ARTHROSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN ARTHROSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GCC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GCC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 173. GCC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 174. GCC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 175. GCC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 176. GCC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 177. GCC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GCC ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION ARTHROSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. G7 ARTHROSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. G7 ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 200. G7 ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 201. G7 ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 202. G7 ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 203. G7 ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 204. G7 ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 205. G7 ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. G7 ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. NATO ARTHROSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. NATO ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 209. NATO ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 210. NATO ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 211. NATO ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 212. NATO ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 213. NATO ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 214. NATO ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. NATO ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL ARTHROSCOPY EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES ARTHROSCOPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA ARTHROSCOPY EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY FLUID MANAGEMENT SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY IMPLANTS, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY VISUALIZATION SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA ARTHROSCOPY EQUIPMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)